Financials
Financial year 2025
Revenue
€ 270.4 million
▼ 3% vs 2024
Profit
Growing€ 13.9 million
▲ 3% vs 2024
Debts
High€ 52.5 million
▼ 2% vs 2024
ELI LILLY EUROPEAN CLINICAL TRIAL SERVICES from Mont-Saint-Guibert, company number BE0888210786, closed financial year 2025 with a result of € 13.9 million after tax. For that financial year ELI LILLY EUROPEAN CLINICAL TRIAL SERVICES recorded revenue of € 270.4 million and equity of € 5 million. Compared with financial year 2024, the result moved from € 13.5 million to € 13.9 million. Profitable, and profit is growing. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 22, 2026.
What happened at ELI LILLY EUROPEAN CLINICAL TRIAL SERVICES?
What happened at ELI LILLY EUROPEAN CLINICAL TRIAL SERVICES in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 13.9 million (▲ 3% vs 2024). Source: NBB ↗
- Benoit LESSIRE stepped down as director. NBB
- Sebastien DELPORTE stepped down as director. NBB
- Benoit LESSIRE became a director. NBB
- Sebastien DELPORTE became a director. NBB
- New establishment in Mont-Saint-Guibert. KBO
- Start of the company according to the CBE. KBO
In short
From € 9.1 million profit in 2021 to € 13.9 million profit in 2025.
Paid € 16 million in corporate taxes since 2021.
Best year ever: 2025, with € 13.9 million profit.
Paid out € 47.5 million in dividends to the owners in total.
A new publication or filing at ELI LILLY EUROPEAN CLINICAL TRIAL SERVICES? We notify you, reason included.
Follow ELI LILLY EUROPEAN CLINICAL TRIAL SERVICESNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
The shares are held by ELI LILLY NETHERLAND BV (100%) and ELI LILLY BENELUX SA (0%).
Directors
According to the 2025 annual accounts
Benoit LESSIRE
Chairman of the board
since 2019 · until 2026
since 2019 · until 2026
Shareholders
ELI LILLY NETHERLAND BV
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Rue Emile Francqui 3
1435 Mont-Saint-Guibert
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 4 companies are registered at this address.
Details
- Company number
- 0888.210.786
- VAT number
- BE 0888.210.786
- Registered office
- Rue Emile Francqui 3, 1435 Mont-Saint-Guibert
- Names & denominations
- ELI LILLY EUROPEAN CLINICAL TRIAL SERVICES
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 22 March 2007
- Peppol
- Active · Active since 1 Jan 2001
- Activities · NACE
Overige zakelijke dienstverlening, n.e.g.
Overige zakelijke dienstverlening, neg
Vervaardiging van medische en tandheelkundige instrumenten en benodigdheden
Vervaardiging van elektrische apparaten voor de geneeskunde, de tandheelkunde en de veeartsenijkunde
Groothandel in chemische producten voor industrieel gebruik
Groothandel in farmaceutische en medische artikelen
Vervaardiging van orthopedische artikelen en prothesen
Groothandel in chemische producten
+2